Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse

Pharmaceutical treatments are being developed to correct specific behavioural and morphological aspects of neurodevelopmental disorders such as mental retardation. Fragile X syndrome is an X-linked mental retardation with abnormal dendritic protrusions from neurons in the brain. Increased signalling...

Full description

Bibliographic Details
Main Authors: Rhiannon M. Meredith, Ruben de Jong, Huibert D. Mansvelder
Format: Article
Language:English
Published: Elsevier 2011-01-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996110002986
id doaj-4a373bc2caab47e883ad1ef135a37e8f
record_format Article
spelling doaj-4a373bc2caab47e883ad1ef135a37e8f2021-03-22T12:35:53ZengElsevierNeurobiology of Disease1095-953X2011-01-01411104110Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouseRhiannon M. Meredith0Ruben de Jong1Huibert D. Mansvelder2Corresponding author. De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands. Fax: +31 20 598 7112.; Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, The NetherlandsDepartment of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, The NetherlandsDepartment of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, The NetherlandsPharmaceutical treatments are being developed to correct specific behavioural and morphological aspects of neurodevelopmental disorders such as mental retardation. Fragile X syndrome is an X-linked mental retardation with abnormal dendritic protrusions from neurons in the brain. Increased signalling via excitatory metabotropic glutamate receptor (mGluR) pathways is hypothesised to contribute to this disorder. Targeting these receptors has shown improvements in both behaviour and morphology with the Fmr1-KO mouse model for the syndrome. It is not known whether similar changes occur in excitatory synaptic activity following treatment with mGluR antagonists.We tested the effects of prolonged mGluR blockade on excitatory synaptic activity at three developmental time points in hippocampal slices. We observed a rescue effect of the antagonist MPEP upon spontaneous EPSC amplitude and charge at 2 weeks but not 1 week or 8–10 weeks of development. These data support the role of mGluR antagonist treatment for functional synaptic correction at an early developmental stage in a model for fragile X syndrome.http://www.sciencedirect.com/science/article/pii/S0969996110002986Fragile X syndromeEPSCGlutamateHippocampusDevelopmentMPEP
collection DOAJ
language English
format Article
sources DOAJ
author Rhiannon M. Meredith
Ruben de Jong
Huibert D. Mansvelder
spellingShingle Rhiannon M. Meredith
Ruben de Jong
Huibert D. Mansvelder
Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
Neurobiology of Disease
Fragile X syndrome
EPSC
Glutamate
Hippocampus
Development
MPEP
author_facet Rhiannon M. Meredith
Ruben de Jong
Huibert D. Mansvelder
author_sort Rhiannon M. Meredith
title Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
title_short Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
title_full Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
title_fullStr Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
title_full_unstemmed Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse
title_sort functional rescue of excitatory synaptic transmission in the developing hippocampus in fmr1-ko mouse
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2011-01-01
description Pharmaceutical treatments are being developed to correct specific behavioural and morphological aspects of neurodevelopmental disorders such as mental retardation. Fragile X syndrome is an X-linked mental retardation with abnormal dendritic protrusions from neurons in the brain. Increased signalling via excitatory metabotropic glutamate receptor (mGluR) pathways is hypothesised to contribute to this disorder. Targeting these receptors has shown improvements in both behaviour and morphology with the Fmr1-KO mouse model for the syndrome. It is not known whether similar changes occur in excitatory synaptic activity following treatment with mGluR antagonists.We tested the effects of prolonged mGluR blockade on excitatory synaptic activity at three developmental time points in hippocampal slices. We observed a rescue effect of the antagonist MPEP upon spontaneous EPSC amplitude and charge at 2 weeks but not 1 week or 8–10 weeks of development. These data support the role of mGluR antagonist treatment for functional synaptic correction at an early developmental stage in a model for fragile X syndrome.
topic Fragile X syndrome
EPSC
Glutamate
Hippocampus
Development
MPEP
url http://www.sciencedirect.com/science/article/pii/S0969996110002986
work_keys_str_mv AT rhiannonmmeredith functionalrescueofexcitatorysynaptictransmissioninthedevelopinghippocampusinfmr1komouse
AT rubendejong functionalrescueofexcitatorysynaptictransmissioninthedevelopinghippocampusinfmr1komouse
AT huibertdmansvelder functionalrescueofexcitatorysynaptictransmissioninthedevelopinghippocampusinfmr1komouse
_version_ 1724208681644457984